Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT

Usefulness of Combined Risk Stratification With Heart Rate and Systolic Blood Pressure in the Management of Chronic Heart Failure

(2013) Masanobu Miura et al.   CIRCULATION JOURNAL

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial

(2012) Andrew P. Ambrosy et al.   AMERICAN HEART JOURNAL

Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study

(2012) Michael Böhm et al.   Clinical Research in Cardiology

Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure

(2012) Mihai Gheorghiade et al.   HEART FAILURE REVIEWS

Relation of Baseline Systolic Blood Pressure and Long-Term Outcomes in Ambulatory Patients With Chronic Mild to Moderate Heart Failure

(2011) Maciej Banach et al.   AMERICAN JOURNAL OF CARDIOLOGY

Bucindolol, Systolic Blood Pressure, and Outcomes in Systolic Heart Failure: A Prespecified Post Hoc Analysis of BEST

(2011) Michel White et al.   CANADIAN JOURNAL OF CARDIOLOGY

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

(2011) Hans-Dirk Düngen et al.   EUROPEAN JOURNAL OF HEART FAILURE

EURObservationalResearch Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)

(2010) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

If Inhibition with Ivabradine

(2009) Irina Savelieva et al.   DRUG SAFETY

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

(2009) J.-C. Tardif et al.   EUROPEAN HEART JOURNAL

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the IfInhibitor Ivabradine Trial (SHIFT)

(2009) Karl Swedberg et al.   EUROPEAN JOURNAL OF HEART FAILURE

Relation of Systolic Blood Pressure to Survival in Both Ischemic and Nonischemic Systolic Heart Failure

(2008) Richard K. Cheng et al.   AMERICAN JOURNAL OF CARDIOLOGY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure

(2008) C E Raphael et al.   HEART

Multiple Neurohumoral Modulating Agents in Systolic Dysfunction Heart Failure: Are We Lowering Blood Pressure Too Much?

(2008) George Mak et al.   JOURNAL OF CARDIAC FAILURE

Chronic Systolic Heart Failure, Guideline-Directed Medical Therapy, and Systemic Hypotension—Less Pressure but Maybe More Risk (Does This Clinical Scenario Need More Discussion?)

(2008) Wayne L. Miller et al.   JOURNAL OF CARDIAC FAILURE

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

(2008) Peter A. Meredith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY